A team from Roswell Park Cancer Institute has discovered a unique population of normal stem cells that may enable prostate cancer relapse. These findings may point the way toward strategies for treating or preventing prostate cancer recurrence.
21-Dec-2017 6:05 PM EST Add to Favorites
In a new study in the journal Nature Communications, a research team from Roswell Park Cancer Institute reports their discovery of a major mechanism by which cells regulate the tumor suppressor p53, opening up new avenues for cancer research and...
12-Dec-2017 5:05 PM EST Add to Favorites
Dr. Eunice Wang was invited to discuss results of a phase II clinical trial of crenolanib for adults with AML at the ASH 2017 annual meeting, and Dr. Kara Kelly, senior author of an oral abstract on outcomes disparities among children and...
11-Dec-2017 9:05 AM EST Add to Favorites
Society for Immunotherapy of Cancer Spearheads Initiative to Align Management of Immunotherapy Side Effects
The first consensus recommendations on recognition and clinical management of immune-related side effects from cancer immunotherapy are published today in the Journal for ImmunoTherapy of Cancer (JITC).
21-Nov-2017 5:05 PM EST Add to Favorites
Researchers at Roswell Park Cancer Institute have initiated a clinical trial based on a unique two-pronged strategy for arming the immune system to more effectively attack cancer cells.
2-Nov-2017 2:05 PM EDT Add to Favorites
In a new study published in Cell Reports, scientists report an unexpected finding — that the oncogene FOXQ1 suppresses the growth of melanoma cells.
28-Sep-2017 4:15 PM EDT Add to Favorites
Roswell Park Cancer has joined the Oncology Research Information Exchange Network, a unique research partnership among North America’s top cancer centers. Members of ORIEN contribute to a shared databank and collaborate on clinical research in...
14-Sep-2017 5:05 PM EDT Add to Favorites
A new study from Roswell Park Cancer Institute reports that women with breast cancer who took multivitamin supplements were less likely to develop chemotherapy-induced neuropathy.
12-Sep-2017 3:05 PM EDT Add to Favorites
25-Jan-2017 10:05 AM EST
Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch
22-Sep-2016 3:05 PM EDT
Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk
27-Oct-2015 5:05 PM EDT
Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT